178368-42-8 Usage
Chemical family
Belongs to the family of thiadiazole derivatives
Structural features
Contains a thiadiazole ring with an ethoxy group at position 3 and a methylsulfonyl group at position 4
Potential applications
Pharmaceutical, agrochemical, and materials science industries
Electronic properties
Unique electronic properties that may contribute to its potential uses in various fields
Structural properties
Unique structural properties that may contribute to its potential uses in various fields
Biological activities
May have biological activities that make it a promising candidate for drug development
Research status
Further research is needed to fully understand its properties and potential uses
Molecular weight
Not provided in the material
Physical state
Not provided in the material (could be solid, liquid, or gas at room temperature)
Solubility
Not provided in the material (ability to dissolve in water or other solvents)
Stability
Not provided in the material (chemical stability under various conditions)
Reactivity
Not provided in the material (reactions with other chemicals or environmental factors)
Toxicity
Not provided in the material (potential harmful effects on humans or the environment)
Check Digit Verification of cas no
The CAS Registry Mumber 178368-42-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,7,8,3,6 and 8 respectively; the second part has 2 digits, 4 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 178368-42:
(8*1)+(7*7)+(6*8)+(5*3)+(4*6)+(3*8)+(2*4)+(1*2)=178
178 % 10 = 8
So 178368-42-8 is a valid CAS Registry Number.
178368-42-8Relevant articles and documents
METHOD FOR TREATING ANXIETY
-
, (2008/06/13)
The present invention provides a method for treating anxiety in humans using azacyclic or azabicyclic compounds.
HETEROCYCLIC COMPOUNDS AND THEIR PREPARATION AND USE
-
, (2008/06/13)
The present invention relates to therapeutically active azacyclic or azabicyclic compounds, a method of preparing the same and to pharmaceutical compositions comprising the compounds. The novel compounds are useful in treating diseases in the central nervous system caused by malfunctioning of the muscarinic cholinergic system.
